{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:13:05Z","timestamp":1767647585932,"version":"3.48.0"},"reference-count":23,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T00:00:00Z","timestamp":1767571200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Zhejiang Provincial Medical and Health Science and Technology Plan Project","award":["2023XY033"],"award-info":[{"award-number":["2023XY033"]}]},{"name":"Zhejiang Pharmaceutical Association's Special Scientific Research Funding Project for Pharmaceutical Management in County-Level Integrated Medical Communities at the Grassroots Level","award":["2021ZYYJC02"],"award-info":[{"award-number":["2021ZYYJC02"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To establish a systematic, standardized, and operational model of home pharmaceutical care for patients with anticoagulant treatment in county-level medical community.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A home pharmaceutical care service team was constituted by pharmacists and physicians from the county-level medical community. A home-based pharmaceutical care survey was conducted for patients with long-term oral anticoagulants (VKAs, rivaroxaban, dabigatran and apixaban). The patients\u2019 awareness and adherence score to oral anticoagulants(OATs) was evaluated before and after home pharmaceutical care service. The awareness and adherence score were evaluated with awareness questionnaires and Morisky Medication Adherence Scale-8 (MMAS-8), respectively. The paired-sample t tests were used to compare the awareness and adherence score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Finally, totally 95 patients completed the survey. Among these patients, 29 patients were in the VKAs group and 66 patients were in the NOACs group. Following the implementation of home pharmaceutical care service, there was an increase in the awareness score, rising from 5.02\u2009\u00b1\u20091.71 to 8.09\u2009\u00b1\u20091.25 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Similarly, the adherence score increased from 4.66\u2009\u00b1\u20091.66 to 6.94\u2009\u00b1\u20090.59 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This pilot study demonstrates that the home pharmaceutical care service model implemented within county-level medical community for anticoagulation treatment is feasible and shows promise in improving anticoagulation knowledge and medication adherence among patients.The findings provide preliminary evidence for a service model that could be further evaluated. Future controlled studies are warranted to confirm its efficacy and to investigate its impact on clinical health outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0339834","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:05:20Z","timestamp":1767639920000},"page":"e0339834","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a home pharmaceutical care service model for home-based patients receiving anticoagulation therapy within county-level medical community"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6465-149X","authenticated-orcid":true,"given":"JianAo","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinhui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KaiZhan","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2026,1,5]]},"reference":[{"issue":"5","key":"pone.0339834.ref001","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.blre.2011.04.003","article-title":"Emerging options in the treatment of deep vein thrombosis and pulmonary embolism","volume":"25","author":"B Brenner","year":"2011","journal-title":"Blood Rev"},{"issue":"4","key":"pone.0339834.ref002","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/s11096-019-00844-0","article-title":"Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise","volume":"41","author":"NL Damen","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"pone.0339834.ref003","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/europace\/euv448","article-title":"Differences in attitude, education, and knowledge about oral anticoagulation therapy among patients with atrial fibrillation in Europe: result of a self-assessment patient survey conducted by the European heart rhythm association","volume":"18","author":"A Hern\u00e1ndez Madrid","year":"2016","journal-title":"Europace"},{"issue":"9","key":"pone.0339834.ref004","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/phar.2158","article-title":"Trends and variation in oral anticoagulant choice in patients with atrial fibrillation, 2010-2017","volume":"38","author":"J Zhu","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"1067","key":"pone.0339834.ref005","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1136\/postgradmedj-2013-132474","article-title":"Direct oral anticoagulants: integration into clinical practice","volume":"90","author":"RPW Cowell","year":"2014","journal-title":"Postgrad Med J"},{"key":"pone.0339834.ref006","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1146\/annurev-med-062209-095159","article-title":"Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism","volume":"62","author":"BI Eriksson","year":"2011","journal-title":"Annu Rev Med"},{"issue":"5","key":"pone.0339834.ref007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/jcpt.12296","article-title":"Evaluation of prescribing and patient use of target-specific oral anticoagulants in the outpatient setting","volume":"40","author":"J Simon","year":"2015","journal-title":"J Clin Pharm Ther"},{"key":"pone.0339834.ref008","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2023.03.010","article-title":"Bleeding related to oral anticoagulants: Trends in US emergency department visits, 2016-2020","volume":"225","author":"AI Geller","year":"2023","journal-title":"Thromb Res"},{"issue":"27","key":"pone.0339834.ref009","first-page":"2137","article-title":"Updated European heart rhythm association practical guide on the use of non-vitamin-k antagonist anticoagulants in patients with non-valvular atrial fibrillation: executive summary","volume":"38","author":"H Heidbuchel","year":"2017","journal-title":"Eur Heart J"},{"issue":"36","key":"pone.0339834.ref010","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the european association for cardio-thoracic surgery (EACTS)","volume":"45","author":"IC Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"pone.0339834.ref011","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.2147\/JMDH.S411330","article-title":"Analysing home pharmaceutical care under the combination of medical care and nursing","volume":"16","author":"Y Zhang","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"pone.0339834.ref012","doi-asserted-by":"crossref","first-page":"6170062","DOI":"10.1155\/2022\/6170062","article-title":"Pharmaceutical Care service at primary health care centers: an insight on patient satisfaction","volume":"2022","author":"M Al Zaidan","year":"2022","journal-title":"Int J Clin Pract"},{"issue":"2","key":"pone.0339834.ref013","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"C Kearon","year":"2016","journal-title":"Chest"},{"issue":"1","key":"pone.0339834.ref014","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11239-018-1652-z","article-title":"Structure and function of anticoagulation clinics in the United States: an AC forum membership survey","volume":"46","author":"GD Barnes","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"pone.0339834.ref015","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.2147\/PPA.S101904","article-title":"Psychometric properties of the Polish version of the eight-item Morisky Medication Adherence Scale in hypertensive adults","volume":"10","author":"B Jankowska-Polanska","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"pone.0339834.ref016","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/jep.12125","article-title":"Translation and validation of a Chinese version of the 8-item Morisky medication adherence scale in myocardial infarction patients","volume":"20","author":"J Yan","year":"2014","journal-title":"J Eval Clin Pract"},{"issue":"2","key":"pone.0339834.ref017","first-page":"268","article-title":"Analysis and practice of reliability and validity evaluation of medication compliance in patients with chronic cardiovascular disease by Chinese version of MMAS-8","volume":"30","author":"Q Chen","year":"2019","journal-title":"China Pharmacy"},{"issue":"1","key":"pone.0339834.ref018","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12877-018-0931-z","article-title":"Home and community-based services coordination for homebound older adults in home-based primary care","volume":"18","author":"GJ Norman","year":"2018","journal-title":"BMC Geriatr"},{"issue":"10","key":"pone.0339834.ref019","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1007\/s12325-016-0394-6","article-title":"Patients\u2019 perspective of medication adherence in chronic conditions: a qualitative study","volume":"33","author":"N Pag\u00e8s-Puigdemont","year":"2016","journal-title":"Adv Ther"},{"key":"pone.0339834.ref020","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.2147\/PPA.S64825","article-title":"Medication adherence behaviors of Medicare beneficiaries","volume":"8","author":"SM Carr-Lopez","year":"2014","journal-title":"Patient Prefer Adherence"},{"issue":"4","key":"pone.0339834.ref021","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.thromres.2015.07.007","article-title":"Self-reported adherence to anticoagulation and its determinants using the Morisky medication adherence scale","volume":"136","author":"LA Castellucci","year":"2015","journal-title":"Thromb Res"},{"issue":"1","key":"pone.0339834.ref022","first-page":"7","article-title":"Assessment of patient adherence to direct oral anticoagulant vs warfarin therapy","volume":"117","author":"SI Patel","year":"2017","journal-title":"J Am Osteopath Assoc"},{"issue":"1","key":"pone.0339834.ref023","doi-asserted-by":"crossref","first-page":"100044","DOI":"10.1016\/j.rpth.2023.100044","article-title":"Knowledge and medication adherence of oral anticoagulant-taking patients in Vietnam","volume":"7","author":"M-H Tran","year":"2023","journal-title":"Res Pract Thromb Haemost"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339834","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T19:05:25Z","timestamp":1767639925000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0339834"}},"subtitle":[],"editor":[{"given":"Ignatius","family":"Ivan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2026,1,5]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0339834","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,5]]}}}